Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujuan Guo

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Cell Death & Disease|May 16, 2025
Cytoplasmic connexin43-microtubule interactions promote glioblastoma stem-like cell maintenance and tumorigenicityJames W Smyth, Sujuan Guo, Lata Chaunsali, et al.
Neuro-Oncology|October 11, 2017
PIK3CB/p110β is a selective survival factor for glioblastomaKevin J Pridham, Lamvy Le, Sujuan Guo, et al.
Annals of Translational Medicine|June 24, 2021
High-fat diet-induced obesity primes fatty acid β-oxidation impairment and consequent ovarian dysfunction during early pregnancyQingying Li, Sujuan Guo, Chengshun Yang, et al.
Nature Food|April 28, 2023
Food and feed trade has greatly impacted global land and nitrogen use efficiencies over 1961-2017Zhaohai Bai, Wenqi Ma, Hao Zhao, et al.
Cancer Research|November 7, 2015
Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to TemozolomideSusan F Murphy, Robin T Varghese, Samy Lamouille, et al.
Cancer Discovery|October 10, 2018
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung CancerShunsuke Kitajima, Elena Ivanova, Sujuan Guo, et al.
Oncogenesis|January 13, 2022
Connexin 43 confers chemoresistance through activating PI3KKevin J Pridham, Farah Shah, Kasen R Hutchings, et al.
Molecular Cancer Therapeutics|November 18, 2021
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent ResistanceMagda Bahcall, Cloud P Paweletz, Yanan Kuang, et al.
Plos One|February 20, 2026
Trends and associations of pulmonary nodule detection rates in China, 2019-2023: A multicenter cross-sectional study based on Real-World DataJingxin Li, Zhouhua Xie, Yiping Chen, et al.
Cancer Cell|September 12, 2018
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRASShunsuke Kitajima, Hajime Asahina, Ting Chen, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Cell Death & Disease|May 16, 2025
Cytoplasmic connexin43-microtubule interactions promote glioblastoma stem-like cell maintenance and tumorigenicityJames W Smyth, Sujuan Guo, Lata Chaunsali, et al.
Neuro-Oncology|October 11, 2017
PIK3CB/p110β is a selective survival factor for glioblastomaKevin J Pridham, Lamvy Le, Sujuan Guo, et al.
Annals of Translational Medicine|June 24, 2021
High-fat diet-induced obesity primes fatty acid β-oxidation impairment and consequent ovarian dysfunction during early pregnancyQingying Li, Sujuan Guo, Chengshun Yang, et al.
Nature Food|April 28, 2023
Food and feed trade has greatly impacted global land and nitrogen use efficiencies over 1961-2017Zhaohai Bai, Wenqi Ma, Hao Zhao, et al.
Cancer Research|November 7, 2015
Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to TemozolomideSusan F Murphy, Robin T Varghese, Samy Lamouille, et al.
Cancer Discovery|October 10, 2018
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung CancerShunsuke Kitajima, Elena Ivanova, Sujuan Guo, et al.
Oncogenesis|January 13, 2022
Connexin 43 confers chemoresistance through activating PI3KKevin J Pridham, Farah Shah, Kasen R Hutchings, et al.
Molecular Cancer Therapeutics|November 18, 2021
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent ResistanceMagda Bahcall, Cloud P Paweletz, Yanan Kuang, et al.
Plos One|February 20, 2026
Trends and associations of pulmonary nodule detection rates in China, 2019-2023: A multicenter cross-sectional study based on Real-World DataJingxin Li, Zhouhua Xie, Yiping Chen, et al.
Cancer Cell|September 12, 2018
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRASShunsuke Kitajima, Hajime Asahina, Ting Chen, et al.
Pageof 5